The Wrap-Up

Dr. Kalaycio: Although an uncommon diagnosis, CML in chronic phase can be treated with an expectation for nearly 100% 5-year survival. For that reason, clinicians need to manage their patients expertly. Steps taken at diagnosis are critical to subsequent decision-making. Once treatment begins, close monitoring is required to screen for side effects as well as ensuring treatment success. With so many effective agents available, patients can be selected for the agent least likely to cause them long-term harm. Perhaps in the future we will learn which patients can stop treatment altogether.

Gentleman, thank you so much for your time. Every time I talk to you I learn something.